First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.42 USD 2.16% Market Closed
Updated: May 1, 2024

Interpace Biosciences Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Interpace Biosciences Inc
Operating Income Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Interpace Biosciences Inc
OTC:IDXG
Operating Income
$1.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Operating Income
$1.6B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
-1%
Quest Diagnostics Inc
NYSE:DGX
Operating Income
$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
2%
CAGR 10-Years
2%
CVS Health Corp
NYSE:CVS
Operating Income
$15.1B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
7%
Cigna Corp
NYSE:CI
Operating Income
$9B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Income
$1.1B
CAGR 3-Years
-34%
CAGR 5-Years
-5%
CAGR 10-Years
2%

See Also

What is Interpace Biosciences Inc's Operating Income?
Operating Income
1.6m USD

Based on the financial report for Sep 30, 2023, Interpace Biosciences Inc's Operating Income amounts to 1.6m USD.